articleNature BiotechnologyJul 24, 2005Closed access

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

DVDavid V MorrisseyJAJennifer A. LockridgeLSLucinda ShawKSKarin S. BlanchardKJKristi Jensen

Mirna Therapeutics (United States)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,162
total citations
FWCI
31.52
Percentile
100%
References
20
Citations per year

Authors

19

Topics & keywords

Topics
Keywords
  • In vivo
  • Small interfering RNA
  • Nucleic acid
  • Hepatitis B virus
  • Dosing
  • RNA
  • Pharmacology
  • Virology
UN Sustainable Development Goals
  • Zero hunger
No related works found for this paper.